Back HIV Populations

HIV Populations

IAS 2015: Raltegravir Prevents Mother-to-Child HIV Transmission During Late Pregnancy

Combination antiretroviral therapy containing the integrase inhibitor raltegravir (Isentress) appears safe and effective and may be an attractive option for treatment of pregnant women with HIV -- and potentially their infants -- to prevent perinatal transmission, according to study findings presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention last week in Vancouver.

alt

Read more:

IAS 2015: Presumptive Treatment of TB in Advanced HIV No Better than ART and Isoniazid

Giving treatment for tuberculosis (TB) to all people with very advanced HIV disease at the time they start antiretroviral therapy (ART), before a laboratory diagnosis of TB -- so-called empiric treatment -- does not reduce the risk of death compared to giving ART and isoniazid preventive therapy, according to findings presented by Mina Hosseinipour at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention this week in Vancouver.

alt

Read more:

Injection Drug Use and Hepatitis C Coinfection Increase Risk of Death for People with HIV

HIV-positive people who inject drugs and those who are coinfected with hepatitis C virus (HCV) have elevated mortality rates, according to a report from the ART Cohort Collaboration published in the July 1 Journal of Acquired Immune Deficiency Syndromes. HIV/HCV coinfected drug injectors had a high risk of liver-related death, but those without HCV still had higher mortality due to various causes compared with non-injectors.

alt

Read more:

Heroin Use Increasing in U.S. Population, Linked to Overdose Deaths, CDC Says

Heroin use has increased among men and women across most age groups and all income levels in recent years, according to the July 7 Vital Signs report from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA). The report urges a 3-prong response, including preventing people from starting heroin use, treating heroin addiction, and using naloxone (Narcan) to prevent overdose deaths.

alt

Read more:

June 5 is National HIV/AIDS Long-Term Survivors Awareness Day

Friday, June 5, is the second annual National HIV/AIDS Long-Term Survivor Awareness Day (NHALTSAD). Coinciding with the anniversary of the first reported casesof the disease that would come to be known as AIDS, in 1981, the day aims to raise awareness about people living with HIV since the early years of the epidemic, many of whom are facing new and unexpected challenges as they age.

alt

Read more: